178 related articles for article (PubMed ID: 1321369)
21. Radiation therapy for intraductal carcinoma. Is it an equal alternative?
Silverstein MJ; Waisman JR; Gierson ED; Colburn W; Gamagami P; Lewinsky BS
Arch Surg; 1991 Apr; 126(4):424-8. PubMed ID: 1848972
[TBL] [Abstract][Full Text] [Related]
22. [10 years' experience with the concept of breast-saving therapy in the treatment of breast cancer].
Staffen A; Stadler B; Strasser K; Schreiner W; Wolner E
Chirurg; 1985 Jul; 56(7):436-9. PubMed ID: 2994965
[TBL] [Abstract][Full Text] [Related]
23. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control?
Stranzl H; Ofner P; Peintinger F
Strahlenther Onkol; 2006 Oct; 182(10):583-8. PubMed ID: 17013571
[TBL] [Abstract][Full Text] [Related]
24. [Conservative treatment of cancer of the breast. Apropos of 108 cases].
Hery M; Namer M; Verschoore J; Monticelli J; Boublil JL; Lalanne CM
J Chir (Paris); 1985 Jan; 122(1):37-41. PubMed ID: 2984224
[TBL] [Abstract][Full Text] [Related]
25. Treatment of intraductal breast cancer--noncomedo type.
Griffin A; Frazee RC
Am Surg; 1993 Feb; 59(2):106-9. PubMed ID: 8386487
[TBL] [Abstract][Full Text] [Related]
26. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
27. [Experiences with an organ-saving and adjuvant-therapy concept in stage 1 breast cancers after 6 years of use within the scope of a controlled clinical study].
Bartl W; Euller A; Nowotny C; Janisch H
Wien Klin Wochenschr; 1986 Jan; 98(1):8-14. PubMed ID: 3006363
[TBL] [Abstract][Full Text] [Related]
28. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
[TBL] [Abstract][Full Text] [Related]
29. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
30. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
31. Sites of failure in breast cancer patients with extracapsular invasion of axillary lymph node metastases. No need for axillary irradiation?!
Gruber G; Menzi S; Forster A; Berclaz G; Altermatt HJ; Greiner RH
Strahlenther Onkol; 2005 Sep; 181(9):574-9. PubMed ID: 16170484
[TBL] [Abstract][Full Text] [Related]
32. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
[TBL] [Abstract][Full Text] [Related]
33. Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes using radiotherapy versus axillary dissection.
Fujimoto N; Amemiya A; Kondo M; Takeda A; Shigematsu N
Cancer; 2004 Nov; 101(10):2155-63. PubMed ID: 15476272
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of breast carcinoma. Our experience].
Sorice G; Fornaro R; Parodi G; Belcastro E
Ann Ital Chir; 1991; 62(5):437-41. PubMed ID: 1666275
[TBL] [Abstract][Full Text] [Related]
35. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?
Gruber G; Berclaz G; Altermatt HJ; Greiner RH
Strahlenther Onkol; 2003 Oct; 179(10):661-6. PubMed ID: 14566473
[TBL] [Abstract][Full Text] [Related]
36. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E
Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
[TBL] [Abstract][Full Text] [Related]
37. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
38. [Postmastectomy radiotherapy for early breast cancer].
Wang S; Li Y; Yu Z
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):68-70. PubMed ID: 11977644
[TBL] [Abstract][Full Text] [Related]
39. A ten year study of medullary carcinoma of the breast.
Maier WP; Rosemond GP; Goldman LI; Kaplan GF; Tyson RR
Surg Gynecol Obstet; 1977 May; 144(5):695-8. PubMed ID: 850851
[TBL] [Abstract][Full Text] [Related]
40. The primary surgical treatment of carcinoma of the breast: a changing trend toward modified radical mastectomy.
Robinson GN; van Heerden JA; Payne WS; Taylor WF; Gaffey TA
Mayo Clin Proc; 1976 Jul; 51(7):433-42. PubMed ID: 933559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
